BBC Virtus LifeSci Biotech Clinical Trials ETF
What is BBC?
BBC tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials.
BBC Factset Analytics Insight
BBC focuses on biotech companies with lead drugs that are still in various phases of clinical trials and not yet approved marketing. Given the low historical success rates in clinical trials, the fund is a high-risk and high-reward bet on a small subset of biotech companies. It excludes companies with a lead drug candidate that’s still in preclinical testing or research stage, prior to entering into human clinical trials. Also excluded are the following 12 distinct sub-industries: Animal Health, Diversified Healthcare, Investment Management, Healthcare Services, Non-Healthcare, Large Pharmaceuticals, Specialty Pharmaceuticals, Medical Devices, Vaccines, Nutraceuticals, OTC Healthcare, or Tools. As such, investors looking for broad biotech exposure, won't find it in BBC. The Index Committee utilizes various public data sources to select portfolio holdings, including, SEC filings, public documents from the U.S. FDA, company press releases and official corporate websites.
BBC Summary Data
BBC Portfolio Data
BBC Index Data
BBC Portfolio Management
BBC Tax Exposures
BBC Fund Structure
Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of BBC. BBC is rated a 4 out of 5.
BBC Sector/Industry Breakdown
BBC Top 10 Holdings
BBC Performance Statistics
BBC Economic Development
BBC Benchmark Comparison Summary
BBC Benchmark Comparison Market Cap Size